LSF Laird Superfood, Inc. Insider Trading

Director Gregory B Graves purchased 15,000 shares of LSF at $3.45; stock currently $3.70, up 23.3% in 30 days.

Gregory B Graves, a director, purchased 15,000 shares at $3.45 on 2026-06-10, increasing his holdings from 60.1K shares to 75.1K shares (a +25.0% increase). The stock has recovered significantly over the past month (+23.3% in 30 days) and remains -52.6% from its 52-week high of $7.80, suggesting the company has faced recent headwinds. However, Graves' cross-ticker track record shows 20 prior buys with an average 90-day return of -9.4% and a 90d win rate of 0.00%, indicating his purchases have historically underperformed within three months. The company generated $13.9M in quarterly revenue with $1.8M net income but was unprofitable over its most recent full fiscal year, adding operational uncertainty to the investment thesis behind this director-level purchase.

Director Grant J Lamontagne purchased 59,950 shares across 4 transactions for $197,217.18 at LSF (avg $3.29), expanding holdings 52.0%.

Grant J Lamontagne executed 4 separate purchases totaling 59,950 shares for $197,217.18 between June 2–5, 2026, increasing his stake from 115,294 shares to 175,244 shares (+52.0%). The blended average price of $3.29 compares to the current price of $3.56, and the stock is up 16.7% over the prior 30 days and up 43.6% over the prior 90 days. His prior 5 purchases at this ticker each realized positive 90-day returns, establishing a consistent pattern of well-timed entry timing at LSF. The company reported $13.9M in quarterly revenue with year-over-year growth of 15.2%, though it remained unprofitable on a full-year basis, suggesting the buying occurred amid revenue momentum but ongoing operational challenges.

Director Grant J Lamontagne bought 30,786 shares ($101.1K) in 5 transactions over 9 days at $3.28–$3.30 (blended avg $3.29), raising holdings by +36.4% to 115.3K shares.

Grant J Lamontagne, a director at Laird Superfood, executed 5 separate purchases totaling 30,786 shares for $101,136.80 over May 20–29, 2026, with a blended average price of $3.29 per share. This represents a 36.4% increase in his shareholding from 84.5K to 115.3K shares. The transaction occurred with the stock trading at $3.38 currently, 56.7% below its 52-week high of $7.80, and comes at a time when the company posted a latest quarterly revenue of $13.9M with net income of $1.8M, though the company was unprofitable over its most recent full fiscal year despite showing annual revenue growth of 15.2%. The multi-transaction pattern over 9 days, combined with concentrated accumulation at prices well below the 52-week peak, provides visibility into director-level capital allocation during a period of depressed valuation relative to recent highs.

LSF CEO Jason Vieth purchases 10,000 shares in 2 transactions ($5.23 and $5.50) totaling $53,650; stock down 45.1% from 52-week high.

Jason Vieth, CEO of Laird Superfood, filed 2 separate purchases totaling 10,000 shares for $53,650.00 at blended average price $5.36 on 2025-03-04, increasing his holdings from 674,969 to 684,969 shares. The company is unprofitable (net income $-166,120.00 in the latest quarter) with a market cap of $56,853,162.72, though annual revenue growth reached +26.5%. The stock trades at $5.52 (current), down 45.1% from its 52-week high of $10.05 and down 23.9% over the prior 30 days. Vieth's own cross-ticker track record shows 1 prior buy with a 90-day win rate of 100.00%, though his same-ticker history at LSF shows that prior 2024 buy experienced a -18.8% 30-day return despite a +40.1% 90-day recovery. The filing reveals insider accumulation during a period of material stock decline, with no contemporaneous public disclosures in the FACTS provided to explain the transaction rationale.

CFO Anna Hamill bought 3,604 shares across 4 transactions in 2 days for $19,996.24, raising stake to 108.5K shares.

Anna Hamill, CFO of Laird Superfood, made 4 separate open-market purchases totaling 3,604 shares for $19,996.24 (blended average $5.55) on March 4–5, 2025. The timing is notable given the stock's sharp recent decline: -45.1% from the 52-week high and -23.9% over the past 30 days. Hamill's own cross-ticker track record shows 1 prior buy at this ticker (2024-03-15) that returned +12.8% at 30 days and +94.6% at 90 days, establishing a pattern of well-timed entry. However, the company's fundamentals remain weak: the latest quarter showed net income of $-166,120.00 despite revenue of $11,776,346.00, and the full fiscal year was unprofitable. The purchase increases her holdings by 3.4% to 108.5K shares in a micro-cap stock ($56.9M market cap), but without additional context on motivation or strategic rationale, the transaction reflects accumulation at depressed prices rather than a clear catalyst signal.